{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:08:59Z","timestamp":1761764939032},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1007\/s11926-003-0060-2","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T13:17:58Z","timestamp":1180790278000},"page":"477-481","source":"Crossref","is-referenced-by-count":3,"title":["Clinical trials in pediatric uveitis"],"prefix":"10.1007","volume":"5","author":[{"given":"Lucila M. A.","family":"Agle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza B.","family":"Vazquez-Cobian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J. A.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","volume":"103","author":"E Bloch-Michel","year":"1987","unstructured":"Bloch-Michel E, Nussenblatt RB: International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987, 103:234\u2013235.","journal-title":"Am J Ophthalmol"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0420.2000.078001084.x","volume":"78","author":"T P\u00e4iv\u00f6nsalo-Hietanen","year":"2000","unstructured":"P\u00e4iv\u00f6nsalo-Hietanen T, Tuominen J, Saari KM: Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand 2000, 78:84\u201388.","journal-title":"Acta Ophthalmol Scand"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1651-2227.2000.tb00416.x","volume":"89","author":"PB Stoffel","year":"2000","unstructured":"Stoffel PB, Sauvain MJ, von Vigier RO, et al.: Non-infectious causes of uveitis in 70 Swiss children. Acta Paediatr 2000, 89:955\u2013958.","journal-title":"Acta Paediatr"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/112067219600600313","volume":"6","author":"P Pivetti-Pezzi","year":"1996","unstructured":"Pivetti-Pezzi P: Uveitis in children. Eur J Ophthalmol 1996, 6:293\u2013298.","journal-title":"Eur J Ophthalmol"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1076\/ocii.8.4.251.6459","volume":"8","author":"ET Cunningham","year":"2000","unstructured":"Cunningham ET: Uveitis in children. Ocul Immunol Inflamm 2000, 8:251\u2013261. Interesting overview of the early epidemiologic studies about uveitis in children.","journal-title":"Ocul Immunol Inflamm"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1067\/mpa.2001.111017","volume":"5","author":"B Oren","year":"2001","unstructured":"Oren B, Sehgal A, Simon JW, et al.: The prevalence of uveitis in juvenile rheumatoid arthritis. J AAPOS 2001, 5:2\u20134.","journal-title":"J AAPOS"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3928\/0191-3913-19980101-13","volume":"34","author":"MI Boone","year":"1998","unstructured":"Boone MI, Moore TL, Cruz OA: Screening for uveitis in juvenile rheumatoid arthritis. J Pediatr Ophthalmol Strabismus 1998, 34:41\u201343.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"60_CR8","first-page":"1026","volume":"145","author":"DD Sherry","year":"1991","unstructured":"Sherry DD, Mellins ED, Wedgewood RJ: Decreasing severity of chronic uveitis in children with pauciarticular arthritis. Am J Dis Child 1991, 145:1026\u20131028.","journal-title":"Am J Dis Child"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/286611a0","volume":"7","author":"JT Rosenbaum","year":"1980","unstructured":"Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR: Endotoxininduced uveitis in rats as a model for human disease. Nature 1980, 7:611\u2013613.","journal-title":"Nature"},{"key":"60_CR10","first-page":"2911","volume":"34","author":"L Kasner","year":"1993","unstructured":"Kasner L, Chan CC, Whitcup SM, Gery I: The paradoxical effect of tumor necrosis factor alpha (TNF-alpha) in endotoxininduced uveitis. Invest Ophthalmol Vis Sci 1993, 34:2911\u20132917.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/eji.1830260510","volume":"26","author":"AD Dick","year":"1996","unstructured":"Dick AD, McMenamin PG, Korner H, et al.: Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol 1996, 26:1018\u20131025.","journal-title":"Eur J Immunol"},{"key":"60_CR12","first-page":"658","volume":"39","author":"JR Smith","year":"1998","unstructured":"Smith JR, Hart PH, Coster DJ, Williams KA: Mice deficient in tumor necrosis factor receptors p55 and p75, interleukin-4, or inducible nitric oxide synthase are susceptible to endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1998, 39:658\u2013661.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"60_CR13","first-page":"2275","volume":"40","author":"O Marie","year":"1999","unstructured":"Marie O, Thillaye-Goldenberg B, Naud MC, de Kozak Y: Inhibition of endotoxin-induced uveitis and potentiation of local TNF-alpha and interleukin-6 mRNA expression by interleukin-13. Invest Ophthalmol Vis Sci 1999, 40:2275\u20132282.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.92.2.295","volume":"92","author":"American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology","year":"1993","unstructured":"American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 1993, 92:295\u2013296.","journal-title":"Pediatrics"},{"key":"60_CR15","first-page":"2253","volume":"29","author":"AM Rosenberg","year":"2002","unstructured":"Rosenberg AM: Uveitis associated with juvenile idiopathic arthritis: envisioning the future. J Rheumatol 2002, 29:2253\u20132255. Brief deep vision of juvenile idiopathic arthritis uveitis-associated disease future.","journal-title":"J Rheumatol"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0161-6420(87)80007-6","volume":"94","author":"MD Wolf","year":"1987","unstructured":"Wolf MD, Lichter PR, Ragsdale CG: Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987, 94:1242\u20131248.","journal-title":"Ophthalmology"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0161-6420(97)30329-7","volume":"104","author":"MR Dana","year":"1997","unstructured":"Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS: Visual outcomes prognosticators in juvenile rheumatoid arthritisassociated uveitis. Ophthalmology 1997, 104:236\u2013244.","journal-title":"Ophthalmology"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.86.1.51","volume":"86","author":"C Edelsten","year":"2002","unstructured":"Edelsten C, Lee V, Bentley CR, et al.: An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 2002, 86:51\u201356.","journal-title":"Br J Ophthalmol"},{"key":"60_CR19","first-page":"2446","volume":"29","author":"F Zulian","year":"2002","unstructured":"Zulian F, Martini G, Falcini F, et al.: Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. J Rheumatol 2002, 29:2446\u20132453.","journal-title":"J Rheumatol"},{"key":"60_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00296-001-0158-7","volume":"21","author":"F Manzotti","year":"2002","unstructured":"Manzotti F, Orsoni JG, Zavota L, et al.: Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences. Rheumatol Int 2002, 21:127\u2013132.","journal-title":"Rheumatol Int"},{"key":"60_CR21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0002-9394(03)00225-3","volume":"135","author":"A Chia","year":"2003","unstructured":"Chia A, Lee V, Graham EM, Edelsten C: Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol 2003, 135:757\u2013762.","journal-title":"Am J Ophthalmol"},{"key":"60_CR22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS, et al.: Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000, 130:492\u2013513.","journal-title":"Am J Ophthalmol"},{"key":"60_CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00128072-200204030-00005","volume":"4","author":"JR Smith","year":"2002","unstructured":"Smith JR: Management of uveitis in pediatric patients. Pediatr Drugs 2002, 4:183\u2013189. Concise enlightenment about diagnosis and treatment of pediatric uveitis.","journal-title":"Pediatr Drugs"},{"key":"60_CR24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jama.280.13.1133","volume":"280","author":"QD Nguyen","year":"1998","unstructured":"Nguyen QD, Foster CS: Saving the vision of children with juvenile rheumatoid arthritis-associated uveitis. JAMA 1998, 280:1133\u20131134.","journal-title":"JAMA"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"EH Giannini","year":"1992","unstructured":"Giannini EH, Brewer EJ, Kuzmina N, et al.: Methotrexate in resistant juvenile rheumatoid arthritis: results of the USAUSSR double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children\u2019s Study Group. N Engl J Med 1992, 326:1043\u20131049.","journal-title":"N Engl J Med"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","volume":"43","author":"P Woo","year":"2000","unstructured":"Woo P, Southwood TR, Prieur AM, et al.: Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000, 43:1849\u20131857.","journal-title":"Arthritis Rheum"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00004397-199203210-00018","volume":"32","author":"RK Hemady","year":"1992","unstructured":"Hemady RK, Baer JC, Foster CS: Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin 1992, 32:241\u2013252.","journal-title":"Int Ophthalmol Clin"},{"key":"60_CR28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0161-6420(93)31568-X","volume":"100","author":"CS Foster","year":"1993","unstructured":"Foster CS, Barrett F: Cataract development and cataract surgery in patients with juvenile rheumatoid arthritisassociated iridocyclitis. Ophthalmology 1993, 100:809\u2013817. prospective evaluation of cataract and JRA uveitis treatment based on a stepladder algorithm approach.","journal-title":"Ophthalmology"},{"key":"60_CR29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0022-3476(98)70232-X","volume":"133","author":"AH Weiss","year":"1998","unstructured":"Weiss AH, Wallace CA, Sherry DD: Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr 1998, 133:266\u2013268.","journal-title":"J Pediatr"},{"key":"60_CR30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3928\/0191-3913-19990501-09","volume":"36","author":"AK Shetty","year":"1999","unstructured":"Shetty AK, Zganjar BE, Ellis GS, Jr., et al.: Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis. J Pediatr Ophthalmol Strabismus 1999, 36:125\u2013128.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0161-6420(96)30683-0","volume":"103","author":"AT Vitale","year":"1996","unstructured":"Vitale AT, Rodriguez A, Foster CS: Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis. Ophthalmology 1996, 103:365\u2013373.","journal-title":"Ophthalmology"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0161-6420(98)91120-4","volume":"105","author":"RC Walton","year":"1998","unstructured":"Walton RC, Nussenblatt RB, Whitcup SM: Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents. Ophthalmology 1998, 105:2028\u20132034.","journal-title":"Ophthalmology"},{"key":"60_CR33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjo.82.7.737","volume":"82","author":"DJ Kilmartin","year":"1998","unstructured":"Kilmartin DJ, Forrester JV, Dick AD: Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol 1998, 82:737\u2013742.","journal-title":"Br J Ophthalmol"},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(74)90229-3","volume":"78","author":"WA Godfrey","year":"1974","unstructured":"Godfrey WA, Epstein WV, O\u2019Connor GR, et al.: The use of chlorambucil in intractable idiopathic uveitis. Am J Ophthalmol 1974, 78:415\u2013428.","journal-title":"Am J Ophthalmol"},{"key":"60_CR35","first-page":"141","volume":"8","author":"R Mehra","year":"1981","unstructured":"Mehra R, Moore TL, Catalano D, et al.: Chlorambucil in the treatment of iridocyclitis in juvenile rheumatoid arthritis. J Rheumatol 1981, 8:141\u2013144.","journal-title":"J Rheumatol"},{"key":"60_CR36","first-page":"967","volume":"12","author":"RG Palmer","year":"1985","unstructured":"Palmer RG, Kanski JJ, Ansell BM: Chlorambucil in the treatment of intractable uveitis associated with juvenile chronic arthritis. J Rheumatol 1985, 12:967\u2013970.","journal-title":"J Rheumatol"},{"key":"60_CR37","first-page":"898","volume":"26","author":"HA Savolainen","year":"1999","unstructured":"Savolainen HA: Chlorambucil in severe juvenile chronic arthritis: long-term follow-up with special reference to amyloidosis. Rheumatology 1999, 26:898\u2013903.","journal-title":"Rheumatology"},{"key":"60_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0161-6420(01)00864-8","volume":"109","author":"E Miserocchi","year":"2002","unstructured":"Miserocchi E, Baltatzis S, Ekong A, et al.: Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience. Ophthalmology 2002, 109:137\u2013142.","journal-title":"Ophthalmology"},{"key":"60_CR39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0161-6420(99)90078-7","volume":"106","author":"G Larkin","year":"1999","unstructured":"Larkin G, Lightman S: Mycophenolate mofetil: a useful immunosuppressive in inflammatory eye disease. Ophthalmology 1999, 106:370\u2013374.","journal-title":"Ophthalmology"},{"key":"60_CR40","first-page":"1285","volume":"42","author":"DJ Kilmartin","year":"2001","unstructured":"Kilmartin DJ, Fletcher ZJ, Almeida JA, et al.: CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis. Invest Ophthalmol Vis Sci 2001, 42:1285\u20131292.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"60_CR41","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"DJ Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A, et al.: Etanercept in children with polyarticular juvenile rheumatoid arthritis: Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000, 342:763\u2013769.","journal-title":"N Engl J Med"},{"key":"60_CR42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/art.10710","volume":"48","author":"DJ Lovell","year":"2003","unstructured":"Lovell DJ, Giannini EH, Reiff A, et al.: Long-term efficacy and safety of etanercept in children with polyarticularcourse juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 2003, 48:218\u2013226.","journal-title":"Arthritis Rheum"},{"key":"60_CR43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5","volume":"45","author":"JR Smith","year":"2001","unstructured":"Smith JR, Levinson RD, Holland GN, et al.: Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 2001, 45:252\u2013257.","journal-title":"Arthritis Rheum"},{"key":"60_CR44","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO;2-O","volume":"44","author":"A Reiff","year":"2001","unstructured":"Reiff A, Takei S, Sadeghi S, et al.: Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum 2001, 44:1411\u20131415.","journal-title":"Arthritis Rheum"},{"key":"60_CR45","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F, et al.: Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003, 48:1093\u20131101.","journal-title":"Arthritis Rheum"},{"key":"60_CR46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0002-9394(03)00314-3","volume":"135","author":"GN Holland","year":"2003","unstructured":"Holland GN, Stiehm ER: Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol 2003, 135:867\u2013878. Recent review of chronic uveitis in children with spotlight on treatment options and complications approach.","journal-title":"Am J Ophthalmol"},{"key":"60_CR47","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/40.8.907","volume":"40","author":"V Gerloni","year":"2001","unstructured":"Gerloni V, Cimaz R, Gattinara M, et al.: Efficacy and safety profile of cyclosporine A in the treatment of juvenile chronic (idiopathic) arthritis: results of a 10-year prospective study. Rheumatology 2001, 40:907\u2013913.","journal-title":"Rheumatology"},{"key":"60_CR48","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0161-6420(03)00092-7","volume":"110","author":"S Baltatzis","year":"2003","unstructured":"Baltatzis S, Tufail F, Yu EN, et al.: Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology 2003, 110:1061\u20131065.","journal-title":"Ophthalmology"},{"key":"60_CR49","doi-asserted-by":"crossref","first-page":"S482","DOI":"10.1002\/art.503","volume":"46","author":"JA Smith","year":"2002","unstructured":"Smith JA, Smith S, Whitcup SM, et al.: The treatment of JRA-associated uveitis with etanercept [abstract]. Arthritis Rheum 2002, 46:S482.","journal-title":"Arthritis Rheum"},{"key":"60_CR50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archopht.121.4.437","volume":"121","author":"CS Foster","year":"2003","unstructured":"Foster CS, Tufail F, Waheed NK, et al.: Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol 2003, 121:437\u2013440.","journal-title":"Arch Ophthalmol"},{"key":"60_CR51","first-page":"S292","volume":"44","author":"V Honkanen","year":"2001","unstructured":"Honkanen V, Lappi M, Koskinen L, Lindahl P: Infliximab treatment in the refractory chronic uveitis of juvenile idiopathic arthritis (JIA) [abstract]. Arthritis Rheum 2001, 44:S292.","journal-title":"Arthritis Rheum"},{"key":"60_CR52","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.96.13.7462","volume":"96","author":"RB Nussenblatt","year":"1999","unstructured":"Nussenblatt RB, Fortin E, Schiffman R, et al.: Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I\/II clinical trial. Proc Natl Acad Sci U S A 1999, 96:7462\u20137466.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"60_CR53","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(02)01932-2","volume":"110","author":"S Foster","year":"2003","unstructured":"Foster S, Papaliodis GN, Chu D: Treatment of ocular inflammatory disorders with daclizumab. Ophtalmology 2003, 110:786\u2013789.","journal-title":"Ophtalmology"},{"key":"60_CR54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1076\/ocii.10.2.83.13977","volume":"10","author":"DJ Thompson","year":"2002","unstructured":"Thompson DJ, Barron KS, Whitcup SM, Robinson MR: The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis. Ocul Immunol Inflamm 2002, 10:83\u201391.","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-003-0060-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-003-0060-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-003-0060-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:23:50Z","timestamp":1683865430000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-003-0060-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s11926-003-0060-2","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}